Dr Griffiths and team are great. Dr Griffiths is a great doctor. She was recommended by my daughter. Excellent choice.
Mary Dean
Myopia Management: Slowing Nearsightedness in Children
How Myopia Management Works
Understanding the goal of myopia management helps set realistic expectations for you and your child. These treatments address the underlying physical change that makes nearsightedness worse over time.
Myopia worsens when the eyeball grows too long from front to back. This is called axial elongation. All myopia management treatments aim to slow this lengthening process, not reverse it. None of these options will reduce your child's existing nearsightedness or eliminate the need for vision correction.
The long-term benefit is that a child who reaches adulthood with lower myopia faces a meaningfully reduced lifetime risk of serious eye conditions, including retinal detachment, glaucoma, and macular degeneration, all of which are more common in people with high myopia.
Starting myopia management earlier generally produces better outcomes. Beginning treatment at the first signs of nearsightedness gives the therapy more years to work before eye growth naturally slows in the late teenage years.
Treatment typically continues through adolescence. Our eye doctors monitor your child's progression at regular intervals and adjust the plan based on how well the current treatment is performing. The goal is to reach adulthood with the lowest prescription possible.
Our eye doctors track two key measurements during myopia management: the prescription strength (measured in diopters) and the axial length of the eye (how long the eye has grown). Axial length measurements provide the most direct evidence that a treatment is slowing eye growth.
It is important to understand that a successful treatment slows progression rather than stopping it entirely. For example, if your child's prescription was increasing by one diopter per year before treatment and is now increasing by half a diopter per year, the therapy is working, even though some progression continues.
Choosing the Right Treatment for Your Child
Several factors influence which myopia management approach is the best fit for your child. Our eye doctors consider age, maturity, daily habits, and family priorities when recommending a plan.
Myopia control spectacle lenses can be used in children as young as 6 and require no special handling. Contact lens options such as MiSight and ortho-K are generally best suited to children ages 8 and older who can manage insertion, removal, and hygiene reliably. Atropine drops can be used at any age but require a consistent nightly routine.
Maturity is often a more useful guide than age alone. A responsible younger child may handle contact lenses very well, while an older child who resists routines may do better with glasses or drops. Our eye doctors will assess your child's readiness alongside the observations you share from home.
Each treatment adds a different level of daily responsibility. Ortho-K requires nightly lens insertion, morning removal, and careful cleaning. Atropine adds one bedtime step. MiSight adds morning insertion and evening disposal. Myopia control glasses require nothing beyond wearing regular glasses.
If your child is very active or plays sports, daytime freedom from glasses can be an important factor. Ortho-K provides clear vision throughout the day without any eyewear. MiSight lenses are worn during the day. Glasses are the simplest option but may feel inconvenient during physical activity.
Myopia management treatments are not always covered by vision insurance, as some plans classify them as specialty services rather than standard vision care. Costs vary depending on the treatment type, required supplies, and fitting fees.
Specialty contact lenses such as MiSight and ortho-K involve ongoing supply costs in addition to initial fitting fees. Atropine drops require a prescription and are typically compounded by a pharmacy, so pricing can vary. Myopia control spectacle lenses have a one-time lens cost with periodic replacement as your child's prescription or frame size changes. Our team is happy to help you understand your coverage options and available payment plans.
The Role of Outdoor Time
In addition to clinical treatments, time spent outdoors plays a meaningful role in slowing myopia progression. This is one of the most accessible tools available to any family, regardless of which treatment plan your child is on.
Research shows that spending at least two hours per day outdoors delays the onset of myopia and may slow its progression in children who are already nearsighted. Bright natural light stimulates the release of dopamine in the retina, a chemical that helps inhibit the eye elongation linked to myopia. This benefit comes from light intensity, not from the type of activities your child does outside.
Outdoor time benefits both children who are not yet myopic (by delaying onset) and children already in treatment (by complementing the effects of their clinical therapy). It is one of the most consistently supported lifestyle factors in myopia research.
Recess, outdoor sports, walking to school, and unstructured play all count toward the daily two-hour goal. The time does not need to be spent all at once. Multiple shorter outdoor periods throughout the day are just as beneficial as one longer session.
Overcast or cloudy days still provide significantly more light intensity than indoor environments, so your child does not need to be in direct sunlight to benefit. While outdoors, wearing UV-protective sunglasses is a good habit to protect the eyes from ultraviolet radiation.
Frequently Asked Questions
These answers address common questions parents have when considering myopia management for their child.
Yes, combining low-dose atropine with ortho-K contact lenses is a recognized approach called combination therapy. This combination has been shown to be more effective than either treatment used alone in children whose myopia is progressing quickly. Our eye doctors typically recommend trying a single treatment first and moving to combination therapy if the initial approach is not producing adequate results.
Treatment generally continues as long as myopia is actively progressing, which is typically through the teenage years. Our eye doctors monitor your child at regular intervals and will consider adjusting or tapering the treatment when measurements show that eye growth has stabilized, often in the late teens or early twenties. Stopping early, before growth stabilizes, may allow progression to resume at its prior rate.
No. Myopia management is designed to slow how much worse nearsightedness becomes, not to remove existing nearsightedness. Your child will still need some form of vision correction throughout childhood. The benefit is that they are likely to reach adulthood with a lower prescription, which carries a lower risk of serious eye health complications over a lifetime.
For many years, eye doctors have prescribed compounded atropine eye drops off-label for myopia management in children. Pharmaceutical-grade atropine formulations specifically for pediatric myopia have been under FDA review, and your eye doctor can discuss the most current options available at the time of your visit. Our team stays current with regulatory developments to ensure we are offering the most appropriate and up-to-date treatments.
Stopping myopia management before eye growth has naturally stabilized can allow progression to resume. Some studies suggest a temporary rebound effect after stopping atropine drops, where progression briefly speeds up before returning to its natural rate. Our eye doctors will discuss the appropriate timing for any changes to your child's treatment plan based on their individual measurements and history.
Yes, particularly if there is a family history of myopia, if your child spends limited time outdoors, or if they have significant near work demands like heavy screen use or reading. An early baseline exam allows our eye doctors to identify risk factors before myopia begins, when preventive strategies such as increased outdoor time can have the greatest impact. Early monitoring also means treatment can begin promptly if myopia does develop.
Talk to Our Eye Doctors About Your Child's Vision
At NewView Eye Center, we are committed to helping children in Northern Virginia protect their long-term eye health through personalized, evidence-based myopia management. If your child has been diagnosed with nearsightedness or has risk factors that concern you, we encourage you to schedule a visit with our team. Earlier conversations lead to earlier treatment, and earlier treatment produces the best outcomes over a lifetime.
What our Patients Says
Explore More
Find more information about our doctors, services, and technology that keep your eyes healthy and your vision at its best.